ADUCANUMAB-AVWA: 411 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
411
Total FAERS Reports
27 (6.6%)
Deaths Reported
85
Hospitalizations
411
As Primary/Secondary Suspect
5
Life-Threatening
2
Disabilities
Prescription
Status
FDA Application: 761178 ·
First Report: 20180101 · Latest Report: 20240615
What Are the Most Common ADUCANUMAB-AVWA Side Effects?
#1 Most Reported
Amyloid related imaging abnormality-oedema/effusion
90 reports (21.9%)
#2 Most Reported
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits
61 reports (14.8%)
#3 Most Reported
Headache
33 reports (8.0%)
All ADUCANUMAB-AVWA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Amyloid related imaging abnormality-oedema/effusion | 90 | 21.9% | 4 | 8 |
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | 61 | 14.8% | 2 | 4 |
| Headache | 33 | 8.0% | 1 | 6 |
| Confusional state | 32 | 7.8% | 3 | 7 |
| Cerebral haemorrhage | 26 | 6.3% | 1 | 5 |
| Dementia alzheimer's type | 22 | 5.4% | 2 | 7 |
| Fall | 21 | 5.1% | 4 | 9 |
| Amyloid related imaging abnormalities | 17 | 4.1% | 0 | 3 |
| Dizziness | 15 | 3.7% | 0 | 2 |
| Brain oedema | 14 | 3.4% | 1 | 5 |
| Cognitive disorder | 13 | 3.2% | 2 | 0 |
| Seizure | 13 | 3.2% | 4 | 6 |
| Superficial siderosis of central nervous system | 13 | 3.2% | 0 | 0 |
| Death | 12 | 2.9% | 12 | 2 |
| Memory impairment | 12 | 2.9% | 0 | 1 |
| Atrial fibrillation | 11 | 2.7% | 1 | 5 |
| Fatigue | 11 | 2.7% | 0 | 1 |
| Covid-19 | 10 | 2.4% | 2 | 3 |
| Gait disturbance | 10 | 2.4% | 3 | 1 |
| Subarachnoid haemorrhage | 9 | 2.2% | 2 | 3 |
Who Reports ADUCANUMAB-AVWA Side Effects? Age & Gender Data
Gender: 50.0% female, 50.0% male. Average age: 73.4 years. Most reports from: US. View detailed demographics →
Is ADUCANUMAB-AVWA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 37 | 7 | 9 |
| 2022 | 158 | 7 | 30 |
| 2023 | 39 | 4 | 12 |
| 2024 | 12 | 3 | 3 |
What Is ADUCANUMAB-AVWA Used For?
| Indication | Reports |
|---|---|
| Dementia alzheimer's type | 341 |
| Product used for unknown indication | 58 |
| Cognitive disorder | 7 |
ADUCANUMAB-AVWA vs Alternatives: Which Is Safer?
ADUCANUMAB-AVWA vs ADVAIR
ADUCANUMAB-AVWA vs ADVAIR HFA
ADUCANUMAB-AVWA vs ADVIL
ADUCANUMAB-AVWA vs AFATINIB
ADUCANUMAB-AVWA vs AFINITOR
ADUCANUMAB-AVWA vs AFLIBERCEPT
ADUCANUMAB-AVWA vs AGALSIDASE ALFA
ADUCANUMAB-AVWA vs AGALSIDASE BETA
ADUCANUMAB-AVWA vs AGOMELATINE
ADUCANUMAB-AVWA vs ALAWAY
Official FDA Label for ADUCANUMAB-AVWA
Official prescribing information from the FDA-approved drug label.